Postantibiotic Effect of Fidaxomicin and Its Major Metabolite, OP-1118, against Clostridium difficile

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antimicrobial Agents and Chemotherapy 2011-09, Vol.55 (9), p.4427-4429
Hauptverfasser:	BABAKHANI, Farah, GOMEZ, Abraham, ROBERT, Nikki, SEARS, Pamela
Format:	Artikel
Sprache:	eng
Schlagworte:	Aminoglycosides Aminoglycosides - metabolism Aminoglycosides - pharmacology Anti-Bacterial Agents Anti-Bacterial Agents - metabolism Anti-Bacterial Agents - pharmacology Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Clostridium difficile Clostridium difficile - drug effects Gastroenterology. Liver. Pancreas. Abdomen Medical sciences Microbial Sensitivity Tests Other diseases. Semiology Pharmacology. Drug treatments Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Susceptibility
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	4429
container_issue	9
container_start_page	4427
container_title	Antimicrobial Agents and Chemotherapy
container_volume	55
creator	BABAKHANI, Farah GOMEZ, Abraham ROBERT, Nikki SEARS, Pamela
description	Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology. For an alternate route to AAC .asm.org, visit: AAC
doi_str_mv	10.1128/aac.00104-11
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1128_AAC_00104_11</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>884423684</sourcerecordid><originalsourceid>FETCH-LOGICAL-a539t-1b2d3e4b8ec9baa3e93a6c039c7d40c9ecf76414c8941c29f0876004ea47864b3</originalsourceid><addsrcrecordid>eNp1ks1v1DAQxS0EokvhxhmZA0JImzKOHce-IK1WLVRq1R7gbE0cZ9erJC62l4__HsMuBQ6crJF_855m3hDynMEZY7V6i2jPABiIirEHZMFAq0o2Wj4kCwApK6FAnJAnKe2g1I2Gx-SkZi1oUGJB3G1IGefsOx-yt_R8GJzNNAz0wvf4LUze-pni3NPLnOg17kKk1y5jF0af3ZLe3BZbppYUN-jnlOl6LILR934_0d4PQ-kf3VPyaMAxuWfH95R8ujj_uP5QXd28v1yvripsuM4V6-qeO9EpZ3WHyJ3mKC1wbdtegNXODq0UTFilBbO1HkC1EkA4FK2SouOn5N1B927fTa63bs4RR3MX_YTxuwnozb8_s9-aTfhiOJMNB14EXh8FYvi8dymbySfrxhFnF_bJKCVEzaUShVweSBtDStEN9y4MzM9gzGq1Nr-CKWXB3xxwTFNtdmEf57KI_7Ev_p7iXvh3agV4dQQwWRyHiLP16Q8nGmgkNIV7eeC2frP96qMzxd2UgzFNY7Qpo7T8By5ArZU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>884423684</pqid></control><display><type>article</type><title>Postantibiotic Effect of Fidaxomicin and Its Major Metabolite, OP-1118, against Clostridium difficile</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>BABAKHANI, Farah ; GOMEZ, Abraham ; ROBERT, Nikki ; SEARS, Pamela</creator><creatorcontrib>BABAKHANI, Farah ; GOMEZ, Abraham ; ROBERT, Nikki ; SEARS, Pamela</creatorcontrib><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology. For an alternate route to AAC .asm.org, visit: AAC </description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/aac.00104-11</identifier><identifier>PMID: 21709084</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Aminoglycosides ; Aminoglycosides - metabolism ; Aminoglycosides - pharmacology ; Anti-Bacterial Agents ; Anti-Bacterial Agents - metabolism ; Anti-Bacterial Agents - pharmacology ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Clostridium difficile ; Clostridium difficile - drug effects ; Gastroenterology. Liver. Pancreas. Abdomen ; Medical sciences ; Microbial Sensitivity Tests ; Other diseases. Semiology ; Pharmacology. Drug treatments ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Susceptibility</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2011-09, Vol.55 (9), p.4427-4429</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011, American Society for Microbiology. All Rights Reserved.</rights><rights>Copyright © 2011, American Society for Microbiology. All Rights Reserved. 2011 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a539t-1b2d3e4b8ec9baa3e93a6c039c7d40c9ecf76414c8941c29f0876004ea47864b3</citedby><cites>FETCH-LOGICAL-a539t-1b2d3e4b8ec9baa3e93a6c039c7d40c9ecf76414c8941c29f0876004ea47864b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165303/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165303/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24505605$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21709084$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BABAKHANI, Farah</creatorcontrib><creatorcontrib>GOMEZ, Abraham</creatorcontrib><creatorcontrib>ROBERT, Nikki</creatorcontrib><creatorcontrib>SEARS, Pamela</creatorcontrib><title>Postantibiotic Effect of Fidaxomicin and Its Major Metabolite, OP-1118, against Clostridium difficile</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology. For an alternate route to AAC .asm.org, visit: AAC </description><subject>Aminoglycosides</subject><subject>Aminoglycosides - metabolism</subject><subject>Aminoglycosides - pharmacology</subject><subject>Anti-Bacterial Agents</subject><subject>Anti-Bacterial Agents - metabolism</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Clostridium difficile</subject><subject>Clostridium difficile - drug effects</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Other diseases. Semiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Susceptibility</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1ks1v1DAQxS0EokvhxhmZA0JImzKOHce-IK1WLVRq1R7gbE0cZ9erJC62l4__HsMuBQ6crJF_855m3hDynMEZY7V6i2jPABiIirEHZMFAq0o2Wj4kCwApK6FAnJAnKe2g1I2Gx-SkZi1oUGJB3G1IGefsOx-yt_R8GJzNNAz0wvf4LUze-pni3NPLnOg17kKk1y5jF0af3ZLe3BZbppYUN-jnlOl6LILR934_0d4PQ-kf3VPyaMAxuWfH95R8ujj_uP5QXd28v1yvripsuM4V6-qeO9EpZ3WHyJ3mKC1wbdtegNXODq0UTFilBbO1HkC1EkA4FK2SouOn5N1B927fTa63bs4RR3MX_YTxuwnozb8_s9-aTfhiOJMNB14EXh8FYvi8dymbySfrxhFnF_bJKCVEzaUShVweSBtDStEN9y4MzM9gzGq1Nr-CKWXB3xxwTFNtdmEf57KI_7Ev_p7iXvh3agV4dQQwWRyHiLP16Q8nGmgkNIV7eeC2frP96qMzxd2UgzFNY7Qpo7T8By5ArZU</recordid><startdate>20110901</startdate><enddate>20110901</enddate><creator>BABAKHANI, Farah</creator><creator>GOMEZ, Abraham</creator><creator>ROBERT, Nikki</creator><creator>SEARS, Pamela</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20110901</creationdate><title>Postantibiotic Effect of Fidaxomicin and Its Major Metabolite, OP-1118, against Clostridium difficile</title><author>BABAKHANI, Farah ; GOMEZ, Abraham ; ROBERT, Nikki ; SEARS, Pamela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a539t-1b2d3e4b8ec9baa3e93a6c039c7d40c9ecf76414c8941c29f0876004ea47864b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Aminoglycosides</topic><topic>Aminoglycosides - metabolism</topic><topic>Aminoglycosides - pharmacology</topic><topic>Anti-Bacterial Agents</topic><topic>Anti-Bacterial Agents - metabolism</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Clostridium difficile</topic><topic>Clostridium difficile - drug effects</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Other diseases. Semiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Susceptibility</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BABAKHANI, Farah</creatorcontrib><creatorcontrib>GOMEZ, Abraham</creatorcontrib><creatorcontrib>ROBERT, Nikki</creatorcontrib><creatorcontrib>SEARS, Pamela</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BABAKHANI, Farah</au><au>GOMEZ, Abraham</au><au>ROBERT, Nikki</au><au>SEARS, Pamela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Postantibiotic Effect of Fidaxomicin and Its Major Metabolite, OP-1118, against Clostridium difficile</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2011-09-01</date><risdate>2011</risdate><volume>55</volume><issue>9</issue><spage>4427</spage><epage>4429</epage><pages>4427-4429</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology. For an alternate route to AAC .asm.org, visit: AAC </abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>21709084</pmid><doi>10.1128/aac.00104-11</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0066-4804
ispartof	Antimicrobial Agents and Chemotherapy, 2011-09, Vol.55 (9), p.4427-4429
issn	0066-4804 1098-6596
language	eng
recordid	cdi_crossref_primary_10_1128_AAC_00104_11
source	MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects	Aminoglycosides Aminoglycosides - metabolism Aminoglycosides - pharmacology Anti-Bacterial Agents Anti-Bacterial Agents - metabolism Anti-Bacterial Agents - pharmacology Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Clostridium difficile Clostridium difficile - drug effects Gastroenterology. Liver. Pancreas. Abdomen Medical sciences Microbial Sensitivity Tests Other diseases. Semiology Pharmacology. Drug treatments Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Susceptibility
title	Postantibiotic Effect of Fidaxomicin and Its Major Metabolite, OP-1118, against Clostridium difficile
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T23%3A46%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Postantibiotic%20Effect%20of%20Fidaxomicin%20and%20Its%20Major%20Metabolite,%20OP-1118,%20against%20Clostridium%20difficile&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=BABAKHANI,%20Farah&rft.date=2011-09-01&rft.volume=55&rft.issue=9&rft.spage=4427&rft.epage=4429&rft.pages=4427-4429&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/aac.00104-11&rft_dat=%3Cproquest_cross%3E884423684%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=884423684&rft_id=info:pmid/21709084&rfr_iscdi=true